# FDA Inspection 822206 - NYU Langone Health Hospital - March 25, 2013

Source: https://www.keypedia.com/records/fda_inspections/nyu-langone-health-hospital/88ce28b4-7c6d-4e4f-bd41-7ea88619ab96
Source feed: FDA_Inspections

> FDA Inspection 822206 for NYU Langone Health Hospital on March 25, 2013. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 822206
- Company Name: NYU Langone Health Hospital
- Inspection Date: 2013-03-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1274509 - 2025-06-27](https://www.keypedia.com/records/fda_inspections/nyu-langone-health-hospital/8aaed731-74a1-49c2-a113-d0e147e46394)
- [FDA Inspection 1274509 - 2025-06-27](https://www.keypedia.com/records/fda_inspections/nyu-langone-health-hospital/e7adbb09-fd64-4aed-94bd-70a855ca6468)
- [FDA Inspection 1250142 - 2024-09-26](https://www.keypedia.com/records/fda_inspections/nyu-langone-health-hospital/577f787a-1e1e-41d3-a2c2-1c14f684f5a8)
- [FDA Inspection 1177868 - 2022-08-19](https://www.keypedia.com/records/fda_inspections/nyu-langone-health-hospital/e801ece3-c66e-4f08-af8e-a27c17316473)
- [FDA Inspection 1177868 - 2022-08-19](https://www.keypedia.com/records/fda_inspections/nyu-langone-health-hospital/8eacf2d8-17ee-4181-a10e-596f80ee6e97)

Company: https://www.keypedia.com/companies/nyu-langone-health-hospital/e2b82a16-2268-4ac3-809e-8e378df0b87d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d